Nautilus Biotechnology, Inc. (NAUT) Tops Q3 EPS by 4c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q3 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Oman Warned European Allies Ship Fees Likely Needed For Hormuz - Bloomberg
• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Wendy's (WEN) call put ratio 3.5 calls to 1 put with a focus on 2800 contracts of July 9 calls